I-Mab Biopharma (‘I-Mab’), headquartered in Shanghai, is different. From its inception in 2015, the company has been focused exclusively on discovering and developing innovative biologics ...
Aug. 28, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the ...
ROCKVILLE, Md., Aug. 26, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a US-based, global, clinical-stage biotech company, exclusively focused on the development of highly differentiated ...